2014 NCCN Case Manager and Medical Director Program™: Challenges in Assessing and Using Biomarkers in Oncology Care
The 2014 NCCN Case Manager and Medical Director Program Live Webinar Series will consist of five webinars on the topics of biomarkers and targeted therapies, breast cancer, cancer survivorship, clinical trials and drug compendia, and pancreatic cancer. This educational series is designed to help case managers and medical directors that are interested in learning more about the current state of the art in oncology care manage patients with cancer based on evidence and according to the recommendations in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®).
This webinar series is designed to meet the educational needs of oncology nurses, case managers, nurses in other roles (i.e., quality management and utilization review), and medical directors at managed care organizations, reinsurers, TPAs, case management, and disease management companies who interact with, counsel, and refer patients with cancer to appropriate sources of care.
Following this activity, participants should be able to:
- Describe the benefits and drawbacks of multiplex mutation testing
- Name several factors to consider when determining the type of biomarker testing to utilize
Wells A. Messersmith, MD
University of Colorado Cancer Center
This activity is approved for AMA PRA Category 1 Credit(s)™. This program has been pre-approved by the Commission for Case Manager Certification to provide continuing education credit to Certified Case Managers (CCMs) and nursing credits are provided as well. View complete accreditation details.
- 1.50 Case Manager
- 1.50 Participation
- 1.50 Nurse
- 1.50 Physician